Company Overview

VERA THERAPEUTICS, INC.

VERA
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-300M
2025 FY
Shares Outstanding
64M
2025 FY
EPS
-4.66USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1831828
Exchange
Nasdaq
Location
US